CD23: a multi-functional receptor/ lymphokine?
Immunology Today, ISSN: 0167-5699, Vol: 10, Issue: 5, Page: 153-157
1989
- 220Citations
- 16Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations220
- Citation Indexes220
- 220
- CrossRef171
- Captures16
- Readers16
- 16
Article Description
With the demonstration of identity between CD23 and the low affinity IgE Fc receptor (FcϵRII), two previously separate avenues of immunological research have converged into one. Particularly in its guise as ‘Blast-2’ antigen, evidence has been mounting to implicate CD23 as an important molecule in B-cell growth regulation. It might seem pertinent, however, to question a role for an apparently isotype-specific immunoglobulin (Ig) receptor in general B-cell processes. In this article, John Gordon and colleagues attempt to reconcile the two, currently diverse, schools of thought regarding the primary function of CD23 and to provide a structural model that accounts for the biological pleiotropy observed.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/0167569989901710; http://dx.doi.org/10.1016/0167-5699(89)90171-0; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=45149143547&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/2525911; https://linkinghub.elsevier.com/retrieve/pii/0167569989901710; http://dx.doi.org/10.1016/0167-5699%2889%2990171-0; https://dx.doi.org/10.1016/0167-5699%2889%2990171-0
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know